Is dabigatran efficacy enough to prevent stroke in atrial fibrillation patient with high CHADS2 score during peri-procedural catheter radiofrequency ablation? A case report with literature review.

about

Growth differentiation factor-15 (GDF-15), novel biomarker for assessing atrial fibrosis in patients with atrial fibrillation and rheumatic heart disease

P2860

Q36493039-87F8C1A1-0E3B-4AD4-B528-62C8421D175F

P2860

Is dabigatran efficacy enough to prevent stroke in atrial fibrillation patient with high CHADS2 score during peri-procedural catheter radiofrequency ablation? A case report with literature review.

Item

http://www.wikidata.org/entity/Q38541307

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Is dabigatran efficacy enough ...... report with literature review.

@en

type

Item

label

Is dabigatran efficacy enough ...... report with literature review.

@en

prefLabel

Is dabigatran efficacy enough ...... report with literature review.

@en

P1476

Is dabigatran efficacy enough ...... report with literature review

@en

P2093

Fu-Kun Chen

http://www.w3.org/2001/XMLSchema#string

Jian Li

http://www.w3.org/2001/XMLSchema#string

Jian-Ping Guo

http://www.w3.org/2001/XMLSchema#string

Kun Lin

http://www.w3.org/2001/XMLSchema#string

Xiang-Min Shi

http://www.w3.org/2001/XMLSchema#string

Zhao-Liang Shan

http://www.w3.org/2001/XMLSchema#string

Zhuo Liang

http://www.w3.org/2001/XMLSchema#string

P2860

The new oral anticoagulants and the future of haemostasis laboratory testing

Dabigatran versus warfarin in patients with atrial fibrillation

Dabigatran etexilate--a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity

Trans-septal catheterization in the electrophysiology laboratory: data from a multicenter survey spanning 12 years.

Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial.

Drug-drug interactions and risk of bleeding among inpatients on warfarin therapy: a prospective observational study

Effects of radiofrequency catheter ablation of atrial fibrillation on soluble P-selectin, von Willebrand factor and IL-6 in the peripheral and cardiac circulation

Rivaroxaban-once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: rationale and design of the ROCKET AF study.

Dabigatran etexilate: a new oral thrombin inhibitor.

Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

P304

6592-6600

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26131290

http://www.w3.org/2001/XMLSchema#string

P921

catheterization

catheter ablation

P932

4483948

http://www.w3.org/2001/XMLSchema#string

Is dabigatran efficacy enough to prevent stroke in atrial fibrillation patient with high CHADS2 score during peri-procedural catheter radiofrequency ablation? A case report with literature review.

about

P2860

P2860

Is dabigatran efficacy enough to prevent stroke in atrial fibrillation patient with high CHADS2 score during peri-procedural catheter radiofrequency ablation? A case report with literature review.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P921

P932

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P921

P932